Type 2 diabetes and hyperglycemia

People taking basal insulin to treat type 2 diabetes experience a significant reduction in the risk for acute complications, which is sustained for at least 2 years after initiating use of the Freestyle Libre, say French researchers.

The humoral immune response to SARS-CoV-2 infection is similar in people with and without diabetes and is not influenced by hyperglycemia, research suggests.

Predictive low glucose alerts are associated with a reduced frequency and severity of rebound hyperglycemia among people using real-time continuous glucose monitoring, show study findings presented at the virtual ADA 80th Scientific Sessions.

Real-world data presented at the virtual ADA 80th Scientific Sessions highlight the benefits of the FreeStyle Libre continuous glucose monitoring system in reducing acute complications in people with type 1 or type 2 diabetes.

Diabetes may present a higher risk to patients with COVID-19 if it is newly diagnosed at hospital admission rather than well established, indicates research from China.

A descriptive analysis of US patients with COVID-19 reports a high in-hospital mortality rate in those with uncontrolled hyperglycemia.

Glycated hemoglobin levels correlate strongly with continuous glucose monitoring-measured average blood glucose and hyperglycemia, but poorly with hypoglycemia, say researchers.

A large proportion of mobile apps for self-management of blood glucose do not provide real-time decision support for users with type 2 diabetes, researchers report.

Researchers show that closed-loop insulin delivery achieves markedly better glucose control than standard insulin management in hospitalized patients with hyperglycemia receiving enteral or parenteral nutrition.

The final version of the 2018 update to the consensus guidelines on managing hyperglycemia in people with type 2 diabetes is now published.

A large proportion of people with documented hyperglycemia are still not clinically diagnosed with type 2 diabetes for up to 1 year later, US study data show.

An analysis of the UK Clinical Practice Research Datalink indicates that elevated glycated hemoglobin levels are associated with an increased risk for infection among patients with diabetes.

Analysis of gene expression changes underlying excess glucose production in the liver has identified a drug – derived from broccoli – with a mechanism of action complementary to that of metformin.

Patients with type 2 diabetes who experience a large reduction in glycated hemoglobin levels within 6 months of starting metformin therapy have a lower risk for adverse outcomes than those who do not achieve early glycemic control, study results suggest.

A study suggests that use of a virtual glucose management service can reduce hyper- and hypoglycemia among inpatients with diabetes by around a third.

Elevated blood glucose within the normal range is associated with increasing arterial stiffness over the long term in participants of the Whitehall II study.

Having a physician who speaks their native language is associated with improved glycemic control among diabetes patients with limited English proficiency, but may be less important for medication adherence, research suggests.

Semaglutide significantly improves glycemic control and reduces bodyweight in treatment-naïve patients with type 2 diabetes, results of the placebo-controlled SUSTAIN 1 trial suggest.

Glucose variability rises with increasingly insulin-dependent forms of diabetes, report researchers.

Researchers believe that guidelines for Type 2 diabetes should specify that exercise should be taken after eating, especially if the meal contains a lot of carbohydrate.